126 related articles for article (PubMed ID: 7686073)
1. Trends in therapy of abnormal airway epithelial ion and liquid transport.
Noone PG; Knowles MR
Monaldi Arch Chest Dis; 1993; 48(2):140-3. PubMed ID: 7686073
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic treatment of abnormal ion transport in the airway epithelium in cystic fibrosis.
Knowles MR; Olivier KN; Hohneker KW; Robinson J; Bennett WD; Boucher RC
Chest; 1995 Feb; 107(2 Suppl):71S-76S. PubMed ID: 7842817
[TBL] [Abstract][Full Text] [Related]
3. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis.
Knowles MR; Clarke LL; Boucher RC
N Engl J Med; 1991 Aug; 325(8):533-8. PubMed ID: 1857389
[TBL] [Abstract][Full Text] [Related]
4. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.
Middleton PG; Geddes DM; Alton EW
Eur Respir J; 1994 Nov; 7(11):2050-6. PubMed ID: 7875281
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis.
Knowles MR; Olivier K; Noone P; Boucher RC
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S65-9. PubMed ID: 7533608
[TBL] [Abstract][Full Text] [Related]
6. Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis.
Bennett WD; Olivier KN; Zeman KL; Hohneker KW; Boucher RC; Knowles MR
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1796-801. PubMed ID: 8665037
[TBL] [Abstract][Full Text] [Related]
7. Cystic fibrosis--from gene to therapy.
Alton EW; Geddes DM
Trans Med Soc Lond; 1991-1992; 108():29-34. PubMed ID: 1727002
[No Abstract] [Full Text] [Related]
8. A dual role for purinergic agonists: closer to effective treatment for cystic fibrosis?
Barker P
Pediatr Res; 2001 Nov; 50(5):552. PubMed ID: 11641445
[No Abstract] [Full Text] [Related]
9. Modulation of the ionic milieu of the airway in health and disease.
Noone PG; Olivier KN; Knowles MR
Annu Rev Med; 1994; 45():421-34. PubMed ID: 8198392
[TBL] [Abstract][Full Text] [Related]
10. Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma.
Schmitt L; Wiebel M; Frese F; Dehnert C; Zugck C; Bärtsch P; Mairbäurl H
Eur Respir J; 2011 Feb; 37(2):342-8. PubMed ID: 20525718
[TBL] [Abstract][Full Text] [Related]
11. Electrolyte transport in the lungs.
Berger HA; Welsh MJ
Hosp Pract (Off Ed); 1991 Mar; 26(3):53-9. PubMed ID: 1706347
[TBL] [Abstract][Full Text] [Related]
12. Abnormal ion permeation through cystic fibrosis respiratory epithelium.
Knowles MR; Stutts MJ; Spock A; Fischer N; Gatzy JT; Boucher RC
Science; 1983 Sep; 221(4615):1067-70. PubMed ID: 6308769
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis affects chloride and sodium channels in human airway epithelia.
Duszyk M; French AS; Man SF
Can J Physiol Pharmacol; 1989 Oct; 67(10):1362-5. PubMed ID: 2482124
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
N Engl J Med; 1990 Apr; 322(17):1189-94. PubMed ID: 2157983
[TBL] [Abstract][Full Text] [Related]
15. CFTR, a regulator of channels.
Kunzelmann K; Schreiber R
J Membr Biol; 1999 Mar; 168(1):1-8. PubMed ID: 10051684
[No Abstract] [Full Text] [Related]
16. Nitric oxide has no beneficial effects on ion transport defects in cystic fibrosis human nasal epithelium.
Rückes-Nilges C; Lindemann H; Klimek T; Glanz H; Weber WM
Pflugers Arch; 2000 Nov; 441(1):133-7. PubMed ID: 11205052
[TBL] [Abstract][Full Text] [Related]
17. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells.
Johnson LG; Boyles SE; Wilson J; Boucher RC
J Clin Invest; 1995 Mar; 95(3):1377-82. PubMed ID: 7533790
[TBL] [Abstract][Full Text] [Related]
18. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
Mall MA
Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
[TBL] [Abstract][Full Text] [Related]
19. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
Knowles MR; Paradiso AM; Boucher RC
Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
[TBL] [Abstract][Full Text] [Related]
20. Inhalation-based therapies in the treatment of cystic fibrosis.
Harris CE; Wilmott RW
Curr Opin Pediatr; 1994 Jun; 6(3):234-8. PubMed ID: 8061731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
